AICPI
LUNG icon

ABG Innovation Capital Partners III’s Pulmonx LUNG Stock Holding History

ABG Innovation Capital Partners III’s Portfolio LUNG Stock Details LUNG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,901
Closed -$93K – 6
2021
Q4 		$93K Sell
2,901
-1,620
-36% -$59.2K 5.38% 4
2021
Q3 		$163K Hold
4,521
– – 6.77% 4
2021
Q2 		$199K Sell
4,521
-828,812
-99% -$36.1M 0.67% 5
2021
Q1 		$38.1M Hold
833,333
– – 18.73% 2
2020
Q4 		$57.5M Buy
+833,333
New +$40.8M 33.86% 2

Other funds holding LUNG

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

ABG Innovation Capital Partners III's LUNG Position: Q1 2022 in Review

ABG Innovation Capital Partners III sold out of Pulmonx (LUNG) in Q1 2022, closing a stake of 2,901 shares — an estimated $93K sold.

ABG Innovation Capital Partners III first reported a position in LUNG in Q4 2020 and held it in 5 quarters. The position peaked at $57.5M in Q4 2020. 109 funds tracked by Wall St. Rank hold LUNG as of Q1 2022.

  • ABG Innovation Capital Partners III reported no remaining Pulmonx position as of Q1 2022 after selling out during the quarter.
  • ABG Innovation Capital Partners III sold 2,901 Pulmonx shares in Q1 2022, an estimated $93K.
  • ABG Innovation Capital Partners III first reported a position in Pulmonx in Q4 2020 and held it in 5 quarters.
  • ABG Innovation Capital Partners III's Pulmonx position peaked at $57.5M in Q4 2020.
  • 109 funds tracked by Wall St. Rank held Pulmonx as of Q1 2022.

Based on ABG Innovation Capital Partners III's 13F filing for Q1 2022, filed 16 May 2022.